DEXCOM INC is 1.0x more valuable than RESMED INC by market capitalization ($29.08 B vs $28.25 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DXCM | RMD |
|---|---|---|
| Market cap | $29.08 B | $28.25 B |
| US-listed rank | #479 | #492 |
| Revenue (latest FY) | $4.66B | $5.15B |
| Net income (latest FY) | $836.30M | $1.40B |
| Net margin | 17.9% | 27.2% |
| P/E (trailing FY) | 34.8 | 20.2 |
| SEC filings | 2,566 | 2,518 |
DEXCOM INC is 1.0x more valuable than RESMED INC by market capitalization ($29.08 B vs $28.25 B).
In their latest fiscal years, DEXCOM INC reported $4.66B in revenue while RESMED INC reported $5.15B.
Full pages: DEXCOM INC and RESMED INC, or browse the full rankings.